CareDx, Inc. (CDNA)

From the record

CareDx, Inc.'s filings since 2017 show 5 warning events of 3 kinds: a notice about its exchange listing (8-K item 3.01, 2 times, the latest 2017-05-22); an auditor change (8-K item 4.01, the latest 2018-04-16); a late-report notice (Form NT 10-K or NT 10-Q, 2 times, the latest 2017-05-15) (its current reports).

From the record

CareDx, Inc.'s 10 filed years say what it did: revenue went from $41 million in fiscal 2016 to $380 million in fiscal 2025, up 28.2% a year; it rose in 8 of 9 years; the deepest fall was 13% from fiscal 2022 to fiscal 2023; net income was positive in 1 of 10 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-12-31, CareDx, Inc.'s diluted share count held steady, and dividends and buybacks returned about 100% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 36 sales (28 under scheduled 10b5-1 plans) and 0 purchases of their own stock on the open market in the year to 2026-11-12 (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-12-31, CareDx, Inc. lost about 7 cents for every dollar of shareholders' money. Leverage: it owed about 27 cents per dollar of assets, and net share issuance: its share count shrank 5.9% over the year (the filed statements).

From the record

CareDx, Inc.'s standing among 24 graded names in its industry family: revenue of $380 million in fiscal 2025 ranks in the top 33% by size; a net margin of -5.6% ranks in the top 31%; revenue growth of 5.7% a year over the last 3 filed years ranks in the bottom 33% (its annual reports).

From the record

CareDx, Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Hanna, John Walter Jr (President and CEO, as filed), filing under that title since 2024-04-25, 2.6 years (bottom 21% of its family); the 13 officers and directors filing in the last fifteen months have been on the record a median of 2.6 years (bottom 10%); 13 officer or director changes were reported on Form 8-K since 2023-11-13, against the 13 people in charge now (bottom 9%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

CareDx, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $65 million against no long-term debt tagged leaves 15.8% of its assets as net cash, top 48% of its family; cash from operations less capital spending is 11.1% of revenue (top 15%); research spending of 18.8% of revenue (top 47%) (its annual report).

From the record

CareDx, Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew 5.7% a year over the last three filed years against 28.2% over all 10, slowing (bottom 24% of its family); the newest year grew 13.8% (bottom 46%); research spending grew -7.5% a year (bottom 25%); capital spending grew 19.3% a year (top 26%) (its annual reports). CareDx, Inc. reported 3 product lines in fiscal 2025: Service at $274 million (72%), Patient and Digital Solutions at $57 million (15%), Product at $48 million (13%); 3 of 3 grew against the year before (its annual report).

From the record

CareDx, Inc.'s newest year against its own record: revenue of $380 million in fiscal 2025 came in 11.7% above the $340 million its prior three years' pace pointed to (top 17% of its family); net income of $21 million against a prior three-year average of $71 million (top 17%); a net margin of -5.6% against -25.3% before (bottom 43%) (its annual reports).